THE ONYCHOMYCOSIS PROBLEM

35 Million Americans suffer from onychomycosis and treatments today are only marginally successful in treating the disease

THE HALLUX SOLUTION

Hallux is developing a subungual topical product for treating onychomycosis that is both safe and highly effective

CLINICAL TRIAL INFORMATION

An open label study of HTS-519 to evaluate efficacy, safety, and tolerability in patients with moderate to severe distal lateral subungual onychomycosis of the Great Toe Nail: A Single Center Phase 2A Trial